10 Stocks Under $5 That Will Explode
On April 8, 2026, in an interview with Reuters, Matt Stucky, chief portfolio manager for equities at Northwestern Mutual Wealth Management Company, discussed his inclination toward small- and mid-cap ...
Neumora Therapeutics Inc. (NMRA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 8,497,822 | $16,570,753 | +36% | 0.46% |
| 2. | SOFTBANK GROUP CORP Masayoshi Son | 6,090,301 | $11,876,087 | -6% | 0.1% |
| 3. | Perceptive Advisors Joseph Edelman | 5,104,097 | $9,952,989 | 0.19% | |
| 4. | MIC Capital Partners Mubadala Investment | 4,460,700 | $8,698,365 | 2.47% | |
| 5. | Millennium Management Israel Englander | 2,754,854 | $5,371,965 | -24% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $11.98 | 3,357 | $40,216.86 | 4,131,207 | 2023-11-14 | Filing | |
| $11.75 | 31,653 | $371,922.75 | 4,127,850 | 2023-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.56 | 6,165 | $21,916.58 | 82,770 | 2026-02-17 | Filing | |
| $3.54 | 5,967 | $21,093.35 | 57,783 | 2026-02-17 | Filing | |
| $3.51 | 9,819 | $34,458.80 | 7,395,185 | 2026-02-17 | Filing | |
| $3.57 | 1,436 | $5,119.34 | 21,034 | 2026-02-17 | Filing | |
| $2.68 | 114,703 | $307,025.52 | 0 | 2025-11-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,891,893 | $7,589,191 | 0% | |
| 2. | 3,498,658 | $6,822,383 | 0% | |
| 3. | 3,309,123 | $6,452,790 | 0.08% | |
| 4. | 2,559,090 | $4,990,226 | 0.11% | |
| 5. | 2,124,143 | $4,142,079 | 3.44% |
News See All
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity
On February 17, Myles Minter from William Blair upgraded his rating on Neumora Therapeutics Inc. (NASDAQ:NMRA) from Market Perform to Outperform.
11 Most Popular AI Penny Stocks to Buy Now
The need for the adoption of Artificial Intelligence (AI) is becoming increasingly pivotal for businesses to elevate their operations.
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511
Neumora Therapeutics Inc (NASDAQ:NMRA) is among the best NASDAQ penny stocks to buy according to analysts.
12 Best NASDAQ Penny Stocks to Buy According to Analysts
Big technology stocks are no longer leading the stock market higher, and a rotation away from large caps is gaining momentum instead.
10 Best New Penny Stocks to Invest In
On December 30, TipRanks reported that the Goldman Sachs portfolio strategy research team is optimistic about small-cap stocks heading into early 2026.
Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the best stocks under $5 with highest upside potential. On October 28, Needham lifted its price target on Neumora Therapeutics, Inc.
14 Stocks Under $5 with Highest Upside Potential
On October 28, Paul Tudor Jones, Tudor Investment Corporation founder and CIO and Robin Hood Foundation founder and board member, appeared on CNBC’s 'Squawk Box' to talk about the latest trends in the...
Neumora Therapeutics Initiates Phase 1 Study for Schizophrenia Drug NMRA-861
Neumora Therapeutics Inc. (NASDAQ:NMRA) is one of the best IPO stocks to buy according to Wall Street analysts.
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Hedge Fund Resource Center